Advertisement
CABA vs NBP
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CABA is a Hold and NBP is a Hold.
CABA in downward trend: 10-day moving average broke below 50-day moving average on September 18, 2026
The 10-day moving average for CABA crossed bearishly below the 50-day moving average on September 18, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 12 of 13 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 90%.
Technical Analysis (Indicators)
Bearish Trend Analysis
The 50-day moving average for CABA moved below the 200-day moving average on September 15, 2026. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where CABA declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.
The Aroon Indicator for CABA entered a downward trend on October 16, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Bullish Trend Analysis
The RSI Indicator shows that the ticker has stayed in the oversold zone for 5 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an Uptrend is expected.
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 4 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
Following a +10.05% 3-day Advance, the price is estimated to grow further. Considering data from situations where CABA advanced for three days, in 226 of 255 cases, the price rose further within the following month. The odds of a continued upward trend are 89%.
CABA may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Fundamental Analysis (Ratings)
The Tickeron Valuation Rating of 18 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.610) is normal, around the industry mean (26.823). P/E Ratio (0.000) is within average values for comparable stocks, (43.395). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (0.000) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (438.009).
The Tickeron Price Growth Rating for this company is 93 (best 1 - 100 worst), indicating slightly worse than average price growth. CABA’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 98 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is 100 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CABA’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.
NBP in -3.03% downward trend, falling for three consecutive days on October 14, 2026
Moving lower for three straight days is viewed as a bearish sign. Keep an eye on this stock for future declines. Considering data from situations where NBP declined for three days, in 305 of 334 cases, the price declined further within the following month. The odds of a continued downward trend are 90%.
Technical Analysis (Indicators)
Bearish Trend Analysis
The Momentum Indicator moved below the 0 level on October 12, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on NBP as a result. In 79 of 88 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 90%.
The Aroon Indicator for NBP entered a downward trend on October 16, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Bullish Trend Analysis
The RSI Indicator shows that the ticker has stayed in the oversold zone for 4 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an Uptrend is expected.
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 3 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
The Moving Average Convergence Divergence (MACD) for NBP just turned positive on October 08, 2026. Looking at past instances where NBP's MACD turned positive, the stock continued to rise in 32 of 39 cases over the following month. The odds of a continued upward trend are 82%.
Following a +3.32% 3-day Advance, the price is estimated to grow further. Considering data from situations where NBP advanced for three days, in 167 of 216 cases, the price rose further within the following month. The odds of a continued upward trend are 77%.
NBP may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Fundamental Analysis (Ratings)
The Tickeron Valuation Rating of 80 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.782) is normal, around the industry mean (26.823). P/E Ratio (38.314) is within average values for comparable stocks, (43.395). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (0.000) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (438.009).
The Tickeron Price Growth Rating for this company is 88 (best 1 - 100 worst), indicating slightly worse than average price growth. NBP’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 97 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is 98 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. NBP’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.
CABA | NBP | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 50 | 50 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 18 Undervalued | 80 Overvalued | |
PROFIT vs RISK RATING 1..100 | 100 | 100 | |
SMR RATING 1..100 | 98 | 97 | |
PRICE GROWTH RATING 1..100 | 93 | 88 | |
P/E GROWTH RATING 1..100 | 100 | 98 | |
SEASONALITY SCORE 1..100 | n/a | n/a |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
CABA's Valuation (18) in the null industry is somewhat better than the same rating for NBP (80). This means that CABA’s stock grew somewhat faster than NBP’s over the last 12 months.
CABA's Profit vs Risk Rating (100) in the null industry is in the same range as NBP (100). This means that CABA’s stock grew similarly to NBP’s over the last 12 months.
NBP's SMR Rating (97) in the null industry is in the same range as CABA (98). This means that NBP’s stock grew similarly to CABA’s over the last 12 months.
NBP's Price Growth Rating (88) in the null industry is in the same range as CABA (93). This means that NBP’s stock grew similarly to CABA’s over the last 12 months.
NBP's P/E Growth Rating (98) in the null industry is in the same range as CABA (100). This means that NBP’s stock grew similarly to CABA’s over the last 12 months.
| CABA | NBP | |
|---|---|---|
| RSI ODDS (%) | 3 days ago 88% | 3 days ago 74% |
| Stochastic ODDS (%) | 3 days ago 82% | 3 days ago 77% |
| Momentum ODDS (%) | N/A | 3 days ago 90% |
| MACD ODDS (%) | N/A | 3 days ago 82% |
| TrendWeek ODDS (%) | 3 days ago 87% | 3 days ago 90% |
| TrendMonth ODDS (%) | 3 days ago 88% | 3 days ago 90% |
| Advances ODDS (%) | 14 days ago 89% | 13 days ago 77% |
| Declines ODDS (%) | 3 days ago 90% | 5 days ago 90% |
| BollingerBands ODDS (%) | 3 days ago 82% | 3 days ago 75% |
| Aroon ODDS (%) | 3 days ago 86% | 3 days ago 90% |
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
CABA’s FA Score shows that 1 FA rating(s) are green while NBP’s FA Score has 0 green FA rating(s).
- CABA’s FA Score: 1 green, 4 red.
- NBP’s FA Score: 0 green, 5 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
CABA’s TA Score shows that 4 TA indicator(s) are bullish while NBP’s TA Score has 5 bullish TA indicator(s).
- CABA’s TA Score: 4 bullish, 4 bearish.
- NBP’s TA Score: 5 bullish, 3 bearish.
Price Growth
CABA (@Biotechnology) experienced а -26.94% price change this week, while NBP (@Biotechnology) price change was -9.68% for the same time period.
The average weekly price growth across all stocks in the @Biotechnology industry was -10.78%. For the same industry, the average monthly price growth was -18.33%, and the average quarterly price growth was -21.56%.
Reported Earning Dates
CABA is expected to report earnings on Nov 05, 2026.
NBP is expected to report earnings on Nov 12, 2026.
Industries' Descriptions
@Biotechnology (-10.78% weekly)Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.
Advertisement
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| LITL | 33.49 | 0.04 | +0.11% |
| Simplify Piper Sandler Us Small-Cap Plus Income ETF | |||
| FLTB | 49.25 | N/A | N/A |
| Fidelity Limited Term Bond ETF (FLTB) | |||
| IBGM | 23.12 | N/A | N/A |
| iShares iBonds Dec 2056 Term Treasury ETF (IBGM) | |||
| CATF | 47.98 | -0.01 | -0.02% |
| American Century California Municipal Bond ETF (CATF) | |||
| FBT | 263.60 | -4.79 | -1.78% |
| First Trust NYSE Arca Biotechnology Index Fund (FBT) | |||
NBP and
Correlation & Price change
A.I.dvisor indicates that over the last year, NBP has been loosely correlated with VCYT. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if NBP jumps, then VCYT could also see price increases.
| Ticker / NAME | Correlation To NBP | 1D Price Change % | ||
|---|---|---|---|---|
| NBP | 100% | -2.33% | ||
| VCYT - NBP | 43% Loosely correlated | -2.86% | ||
| INDP - NBP | 39% Loosely correlated | -7.72% | ||
| IMNM - NBP | 37% Loosely correlated | -5.34% | ||
| CABA - NBP | 37% Loosely correlated | -9.03% | ||
| VSTM - NBP | 35% Loosely correlated | -6.28% | ||
More | ||||